
MD Biosciences is accredited by AAALAC International, demonstrating globally recognized excellence in animal care beyond regulatory standards.
The scientific team specializes in pain and neurodegenerative disease models, including pig models built for clinical translation. Histology, biomarker analysis and electrophysiology are run in house, so each study is designed around the readouts the program needs.
Studies are run by experienced teams at every step, from surgery to dosing, producing data that supports confident decisions through the development program.
Sponsors have direct access to the scientists for customized study design. Studies typically start within 4 to 6 weeks of a signed statement of work.

MD Biosciences is accredited by AAALAC International, demonstrating globally recognized excellence in animal care beyond regulatory standards.

The 20,000 square foot GLP facility supports translational research with dedicated rodent and pig labs, histology, biomarker, electrophysiology, and in vitro capabilities.

MD Biosciences holds an NIH Office of Laboratory Animal Welfare Foreign Assurance, confirming compliance with NIH animal care standards and enabling support of NIH-funded research conducted outside the United States.
MD Biosciences is a signatory to the Marseille Declaration, the first collective pharmaceutical industry commitment to advancing standards in animal housing and care. This reflects a commitment to the highest levels of animal welfare.
Weeks or Less to Study Start
Customizable Models
Expert Scientists
Publications
Chief Executive Officer
Chief Scientific Officer
VP Business Development
Head of Electrophysiology and In Vitro
Head of Histology and Immunohistochemistry
Head of Large Animals
Head of Preclinical Rodent Studies
Head of Preclinical Rodent Studies
45 Prospect Street
Cambridge, MA 02139
T: (617) 764 6555
4 Eli Horovitz St
Rehovot, Israel
T: +972 (08) 939 6884